课题基金 / 基金详情

Small Animal PET/SPECT/CT Molecular Imaging

Small Animal PET/SPECT/CT Molecular Imaging
小动物 PET/SPECT/CT 分子成像
批准号:
8053517
负责人:
BENNETT B CHIN
金额:
$60.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2012-03-31

项目摘要

项目成果

BENNETT B CHIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal is to obtain funding for a state-of-the-art small animal PET/CT molecular imaging instrument. Our institution has committed resources to support, develop and maintain this instrument. It will provide small animal high resolution in vivo radionuclide molecular imaging with precise anatomic correlation using computed tomography (CT). High-resolution positron emission tomography (PET) provides a non-invasive method to visualize molecular events in vivo. This is critical to medical science investigations because it will enable basic science studies of in vivo mechanisms of disease. Oncologists, cardiologists, and other investigators throughout the University and Medical Center will be able to perform longitudinal, in vivo molecular imaging studies in contemporary small animal models. The basic science of radiochemistry will also tremendously benefit through testing and development of novel radiotracers in vivo. Radio chemists can efficiently determine the in vivo biodistribution, radiation dosimetry, and radiotracer kinetics of novel radiotracers. Furthermore, advanced therapeutics can also be tested and developed in in vivo small animal models, using radiotracers which can monitor the early molecular events of a therapeutic response. A wide array of advanced therapeutics may include both novel drug compounds and novel strategies such as cell based therapies. In addition to contributing to understanding basic mechanisms of pathophsiology, radiotracer techniques have proven human safety for both diagnostic and therapeutic applications. Novel radiotracers, radiotracer methods, and therapeutic monitoring techniques are, therefore, highly translational to in vivo human studies. PUBLIC HEALTH RELEVANCE: We plan to use this instrument to study the reasons why medical diseases occur, to test new methods to detect disease, and to test new therapies before they are used in humans. This can greatly advance medical science and the treatment of cancer, heart disease, and a wide variety of other human diseases. Studying disease in live tissues is essential to understanding how diseases occur, testing new non-invasive tests, and testing safety and efficacy of new therapies before human use.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/cts.12464
发表时间: 2017-09
期刊: Clinical and translational science
影响因子: --
作者: [Burt T, Noveck RJ, MacLeod DB, Layton AT, Rowland M, Lappin G]
通讯作者: Lappin G
Geles: A Novel Imaging Informatics System for Generalizable Lesion Identification in Neuroendocrine Tumors
  • 批准号:
    10740578
  • 项目类别:
  • 资助金额:
    $38.85万
  • 财政年份:
    2023
  • 负责人:
    BENNETT B CHIN
  • 依托单位:
MRI OF MURINE CARDIAC FUNCTION
  • 批准号:
    7601209
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2007
  • 负责人:
    BENNETT B CHIN
  • 依托单位:
海外基金